TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer
Authors:
- 4 July 2017
- book chapter
- Published by Springer Nature
- p. 27-57
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAILCell Death & Disease, 2012
- Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivityCell Death & Disease, 2012
- Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8 + T-cell immunityProceedings of the National Academy of Sciences, 2011
- Natural killer cells act as rheostats modulating antiviral T cellsNature, 2011
- Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC levelCell Death & Differentiation, 2010
- Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteinsCell Death & Disease, 2010
- Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus InfectionGastroenterology, 2010
- Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancerJournal of Molecular Medicine, 2009
- Osteoclast differentiation and activationNature, 2003
- TRAIL-β and TRAIL-γ: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potentialBritish Journal of Cancer, 2003